BSE - Delayed Quote INR

Ind-Swift Laboratories Limited (INDSWFTLAB.BO)

Compare
121.55 -2.45 (-1.98%)
At close: 3:15 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
10,037,275.00
12,808,999.00
12,073,100.00
10,387,336.00
8,913,445.00
--
Cost of Revenue
5,265,130.00
6,614,639.00
6,555,840.00
6,291,203.00
5,162,399.00
--
Gross Profit
4,772,145.00
6,194,360.00
5,517,260.00
4,096,133.00
3,751,046.00
--
Operating Expense
3,327,164.00
4,185,327.00
3,798,907.00
3,171,903.00
2,641,450.00
--
Operating Income
1,444,981.00
2,009,033.00
1,718,353.00
924,230.00
1,109,596.00
--
Net Non Operating Interest Income Expense
-308,882.00
-511,036.00
-921,664.00
-949,837.00
-997,041.00
--
Pretax Income
5,511,012.00
5,817,572.00
865,212.00
125,324.00
180,085.00
--
Tax Provision
1,460,368.00
1,603,055.00
386,903.00
146,814.00
211,557.00
--
Net Income Common Stockholders
4,046,547.00
4,209,616.00
475,966.00
-21,490.00
-31,472.00
--
Average Dilution Earnings
--
--
--
--
--
42,392.00
Diluted NI Available to Com Stockholders
4,046,547.00
4,209,616.00
475,966.00
-21,490.00
-31,472.00
--
Basic EPS
68.48
71.24
8.06
-4.28
-4.28
--
Diluted EPS
68.48
71.24
8.06
-4.28
-4.28
--
Basic Average Shares
58,945.48
59,090.62
59,052.85
59,086.87
59,086.86
--
Diluted Average Shares
58,945.48
59,090.62
59,052.85
59,086.87
59,086.86
--
Rent Expense Supplemental
--
--
7,451.00
5,158.00
5,371.00
8,355.00
Total Expenses
8,592,294.00
10,799,966.00
10,354,747.00
9,463,106.00
7,803,849.00
--
Net Income from Continuing & Discontinued Operation
4,046,547.00
4,209,616.00
475,966.00
-21,490.00
-31,472.00
--
Normalized Income
1,205,075.30
1,408,980.05
662,500.60
74,174.10
-31,472.00
--
Interest Income
--
--
58,720.00
5,621.00
5,128.00
13,638.00
Interest Expense
308,882.00
511,036.00
921,664.00
914,528.00
933,532.00
--
Net Interest Income
-308,882.00
-511,036.00
-921,664.00
-949,837.00
-997,041.00
--
EBIT
5,819,894.00
6,328,608.00
1,786,876.00
1,039,852.00
1,113,617.00
--
EBITDA
6,216,567.00
6,861,636.00
2,360,498.00
2,350,239.00
1,986,534.00
--
Reconciled Cost of Revenue
5,265,130.00
6,614,639.00
6,555,840.00
6,291,203.00
5,162,399.00
--
Reconciled Depreciation
396,673.00
533,028.00
573,622.00
1,310,387.00
872,917.00
--
Net Income from Continuing Operation Net Minority Interest
4,046,547.00
4,209,616.00
475,966.00
-21,490.00
-31,472.00
--
Total Unusual Items Excluding Goodwill
3,865,900.00
3,865,900.00
-266,478.00
-136,663.00
--
--
Total Unusual Items
3,865,900.00
3,865,900.00
-266,478.00
-136,663.00
--
--
Normalized EBITDA
2,350,667.00
2,995,736.00
2,626,976.00
2,486,902.00
1,986,534.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
1,024,428.30
1,065,264.05
-79,943.40
-40,998.90
--
--
3/31/2020 - 11/4/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers